Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR) Meeting Abstract


Authors: Feldman, D. R.; Stadler, W. M.; Appleman, L. J.; Quinn, D. I.; Costello, B. A.; Schwartz, G. K.; Reuter, V. E.; Woo, K.; Patil, S.; Fusco, A.; Smith, S. C.; Carlson, J.; Bosl, G. J.; Motzer, R. J.
Abstract Title: Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR)
Meeting Title: 2014 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 32
Issue: 4 Suppl.
Meeting Dates: 2014 Jan 30-Feb 1
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2014-02-01
Language: English
ACCESSION: WOS:000335318100365
PROVIDER: wos
Notes: Meeting Abstract: 364 -- Genitourinary Cancers Symposium -- JAN 30-FEB 01, 2014 -- San Francisco, CA -- S -- Source: Wos
MSK Authors
  1. Sujata Patil
    382 Patil
  2. Robert Motzer
    744 Motzer
  3. Gary Schwartz
    358 Schwartz
  4. Darren Richard Feldman
    171 Feldman
  5. Victor Reuter
    899 Reuter
  6. George Bosl
    255 Bosl
  7. Anne Fusco
    4 Fusco
  8. Sloane Camille Baptiste Smith
    6 Smith
  9. Kaitlin Marie Woo
    97 Woo